Consensus SI-BONE, Inc.

Equities

SIBN

US8257041090

Market Closed - Nasdaq 21:00:00 30/04/2024 BST 5-day change 1st Jan Change
14.26 USD -2.66% Intraday chart for SI-BONE, Inc. -6.61% -32.06%

Evolution of the average Target Price on SI-BONE, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2851db653b3.SuQ489_OUT7er2e2ZTlnIbjd8QaI8-_mRNaXDPgsa2E.DpNclr6aHl-fyijCAXU-doGYmVHAtr6hCqD4X5UVGCITlXGai6QaE5bgVw~39db4d3a94eb474a91a1ae68fb4211ef
Piper Sandler Initiates SI-Bone With Overweight Rating, Price Target is $25 MT
Morgan Stanley Raises SI-Bone Price Target to $26 From $25, Maintains Overweight Rating MT
Truist Securities Adjusts SI-Bone Price Target to $24 From $26, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on SI-Bone to $26 From $25, Maintains Buy Rating MT
Truist Securities Raises SI-Bone Price Target to $25 From $22, Maintains Buy Rating MT
Cantor Fitzgerald Adjusts SI-Bone's Price Target to $25 From $30, Maintains Overweight Rating MT
Morgan Stanley Adjusts Price Target on SI-Bone to $25 From $30, Maintains Overweight Rating MT
Needham Adjusts Price Target on SI-Bone to $25 From $32, Maintains Buy Rating MT
BofA Trims Price Target on SI-Bone to $24 From $33, Keeps Buy Rating MT
Truist Securities Adjusts Price Target on SI-Bone to $33 From $28, Maintains Buy Rating MT
Needham Adjusts Price Target on SI-Bone to $32 From $27, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on SI-Bone to $30 From $27, Maintains Overweight Rating MT
Morgan Stanley Adjusts Price Target on SI-Bone to $27 From $22, Maintains Overweight Rating MT
Cantor Fitzgerald Adjusts Price Target on SI-Bone to $30 From $24, Maintains Overweight Rating MT
Needham Adjusts Price Target on SI-Bone to $27 From $24, Maintains Buy Rating MT
Canaccord Genuity Raises Price Target on SI-Bone to $27 From $24, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on SI-Bone to $26 From $21, Maintains Buy Rating MT
Needham Adjusts Price Target on SI-Bone to $24 From $20, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on SI-Bone to $22 From $18, Maintains Overweight Rating MT
Canaccord Genuity Adjusts Price Target on SI-Bone to $24 From $21, Maintains Buy Rating MT
Cantor Fitzgerald Adjusts Price Target on SI-Bone to $24 From $22, Maintains Overweight Rating MT
Truist Securities Adjusts Price Target on SI-Bone to $21 From $17, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on SI-Bone to $18 From $21, Maintains Overweight Rating MT
Truist Securities Adjusts Price Target on SI-Bone to $17 From $20, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on SI-Bone to $21 From $22, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
14.26 USD
Average target price
26.22 USD
Spread / Average Target
+83.89%
High Price Target
32 USD
Spread / Highest target
+124.40%
Low Price Target
20 USD
Spread / Lowest Target
+40.25%

Consensus detail

Consensus revision (last 18 months)

Analysts covering SI-BONE, Inc.

Piper Sandler
Morgan Stanley
Truist Securities
Cantor Fitzgerald
Needham & Co.
BofA Securities
Canaccord Genuity
JMP Securities
Jefferies & Co.
Citigroup
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. SIBN Stock
  4. Consensus SI-BONE, Inc.